700 KRW
6.00 B KRW
41.87 B KRW
5.95 M
About CHOONG ANG VACCINE LABORATORY
Sector
CEO
In-Joong Yoon
Headquarters
Daejeon
Website
Founded
1968
ISIN
KR7072020001
FIGI
BBG000BSZL46
Choong Ang Vaccine Laboratory Co., Ltd. engages in the manufacture and sale of animal medicines and products. Its products include feed additives, insect repellants, disinfectants, and animal vaccines for pigs, birds, dogs, cows, and others. The company was founded on December 6, 1968 and is headquartered in Daejeon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 072020 is 9,800 KRW — it has increased by 0.51% in the past 24 hours. Watch CHOONG ANG VACCINE LABORATORY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CHOONG ANG VACCINE LABORATORY stocks are traded under the ticker 072020.
072020 stock has fallen by −0.20% compared to the previous week, the month change is a −2.20% fall, over the last year CHOONG ANG VACCINE LABORATORY has showed a −10.26% decrease.
072020 reached its all-time high on Jun 10, 2016 with the price of 33,690 KRW, and its all-time low was 1,530 KRW and was reached on May 11, 2004. View more price dynamics on 072020 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
072020 stock is 2.26% volatile and has beta coefficient of 0.33. Track CHOONG ANG VACCINE LABORATORY stock price on the chart and check out the list of the most volatile stocks — is CHOONG ANG VACCINE LABORATORY there?
Today CHOONG ANG VACCINE LABORATORY has the market capitalization of 93.20 B, it has decreased by −0.10% over the last week.
Yes, you can track CHOONG ANG VACCINE LABORATORY financials in yearly and quarterly reports right on TradingView.
072020 net income for the last quarter is 932.80 M KRW, while the quarter before that showed 2.07 B KRW of net income which accounts for −54.97% change. Track more CHOONG ANG VACCINE LABORATORY financial stats to get the full picture.
Yes, 072020 dividends are paid annually. The last dividend per share was 150.00 KRW. As of today, Dividend Yield (TTM)% is 1.54%. Tracking CHOONG ANG VACCINE LABORATORY dividends might help you take more informed decisions.
CHOONG ANG VACCINE LABORATORY dividend yield was 1.36% in 2023, and payout ratio reached 24.15%. The year before the numbers were 0.91% and 24.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 31, 2024, the company has 178.00 employees. See our rating of the largest employees — is CHOONG ANG VACCINE LABORATORY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHOONG ANG VACCINE LABORATORY EBITDA is 13.57 B KRW, and current EBITDA margin is 29.87%. See more stats in CHOONG ANG VACCINE LABORATORY financial statements.
Like other stocks, 072020 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHOONG ANG VACCINE LABORATORY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHOONG ANG VACCINE LABORATORY technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHOONG ANG VACCINE LABORATORY stock shows the sell signal. See more of CHOONG ANG VACCINE LABORATORY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.